Benefit 01
Recovery
Support.
Potential recovery support is one of the goals listed for this growth-hormone-axis blend.
Botox & Filler Lab
Explore the 20 mg Tesamorelin + 10 mg Ipamorelin blend and its supplied product guide.
View guide30 mg / 2 ml
Combined formulaThe benefits of Tesamorelin + Ipamorelin
Explore the goals listed in the supplied product information. Individual suitability and results vary.
Benefit 01
Potential recovery support is one of the goals listed for this growth-hormone-axis blend.
Showing Recovery Support, benefit 1 of 4
Your Tesamorelin / Ipamorelin guide
Explore the listed ingredients, product presentation, and supplied directions.
Overview
2X Blend Tesamorelin / Ipamorelin
30 mg total blend in 2 mL
Ingredients
2X Blend Tesamorelin / Ipamorelin
See the supplied directions below.
Directions
The dose section includes the product-specific instructions and safety information.
Your clinic
Review product suitability, availability, and next steps with the clinic.
Educational overview only. Individual results vary, treatment is not appropriate for everyone, and all care decisions should be made with a licensed clinician.
Dose referenceAlpha BioMed reference protocol
Review the supplied Tesamorelin / Ipamorelin vial, concentration, unit reference, and supporting guidance in one clear place.
30 mg / 2 ml
Combined formulaVial strength
30 mg / 2 mlProvider-supplied example
D = day in the supplied seven-day pattern, not a named weekday. Illustration of the supplied example, not a treatment duration. Confirm start date, spacing, and duration with your clinician.
10 units SQ, 5 days on and 2 days off. Tesamorelin is best injected at night before bed; Ipamorelin follows the same schedule.
At the listed prepared volume (30 mg in 2 mL), 10 U-100 syringe units = 0.1 mL = 1.5 mg total blend. The amount is for the combined blend, not each ingredient. Confirm the exact product concentration and prescribed schedule with the clinic.
Preparation & use
Select the reference that matches your product and prescribed regimen.
Add 2 ml BAC water to the vial. Inject it slowly down the inside wall of the vial, then gently swirl until dissolved; do not shake. Use sterile technique.
10 U-100 syringe units = 0.1 mL = 1.5 mg total blend.
Self-injection: SQ (subcutaneous). Use fatty tissue such as the abdomen, outer thigh, or back of upper arm; rotate sites each dose and avoid irritated, bruised, scarred, or damaged skin. For abdomen, stay at least 2 inches from the navel.
Only increase or change dose according to the listed protocol. Follow titration instructions when applicable; do not increase faster than the protocol.
Storage & safety
Store at 20º - 25ºC (68º - 78ºF). Protect from light. Refrigerate after first reconstitution.
Possible side effects. Injection redness, joint pain, and mild edema.
Pause and get help. Pause use and get help for red flag symptoms, unexpected side effects, dose errors, missed doses with symptoms, pregnancy, new diagnosis, new medication, or uncertainty about storage/reconstitution.
Urgent symptoms. Severe allergic reaction, trouble breathing, chest pain, fainting, severe abdominal pain, persistent vomiting, severe swelling, infection signs, or rapidly worsening symptoms require urgent medical help.
Video tutorial
Watch the supplied technique overview, then follow the instructions from your licensed provider and dispensing pharmacy.
Tesamorelin / Ipamorelin support
Clear answers for the most common questions about use, storage, safety, and the supplied vial protocol.
The blend contains 20 mg Tesamorelin and 10 mg Ipamorelin per vial, for 30 mg total.
It may be a good fit if you want support for recovery, active lifestyle goals, restorative routines, and a more structured wellness plan.
This blend is not recommended during pregnancy, breastfeeding, or while trying to conceive unless a licensed medical provider specifically clears it for you.
10 units SQ, 5 days on and 2 days off. Tesamorelin is best injected at night before bed; Ipamorelin follows the same schedule.
Add 2 ml BAC water to the vial. Inject it slowly down the inside wall of the vial, then gently swirl until dissolved; do not shake. Use sterile technique.
Self-injection: SQ (subcutaneous). Use fatty tissue such as the abdomen, outer thigh, or back of upper arm; rotate sites each dose and avoid irritated, bruised, scarred, or damaged skin. For abdomen, stay at least 2 inches from the navel.
4 weeks This is the supplied course or supply note; it is not an after-mixing expiry date. Calculated vial draws are shown separately.
Store at 20º - 25ºC (68º - 78ºF). Protect from light. Refrigerate after first reconstitution.
Pregnant/breastfeeding clients, minors, clients with active infection, uncontrolled medical conditions, severe allergies, or complex medication histories should complete safety review before use. Cancer history, endocrine disorders, uncontrolled diabetes, edema, or growth-hormone-axis concerns should complete safety review before use.
Injection redness, joint pain, and mild edema.
Pause use and get help for red flag symptoms, unexpected side effects, dose errors, missed doses with symptoms, pregnancy, new diagnosis, new medication, or uncertainty about storage/reconstitution.
Severe allergic reaction, trouble breathing, chest pain, fainting, severe abdominal pain, persistent vomiting, severe swelling, infection signs, or rapidly worsening symptoms require urgent medical help.
Talk with the team before starting or changing your protocol.
This FAQ is educational and does not replace the advice, diagnosis, prescription, or product-specific instructions of a licensed healthcare professional.
Personalized care, thoughtfully guided
Tell us what you’re looking for. Our team will listen, answer your questions, and help you choose the right next step.